Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 16, 2022 Filed Feb 18, 2022 21:36 UTC | GrantEmployee Stock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $0.79 | $0.00 |
DisclosureSEC source: 0001209191-22-011313 · doc4.xml · derivative · entry 1 Ahlholm Frederick W · CIK 0001405279 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2032-02-15 F1 · derivative.exercise_date: The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter. Read SEC document |
|
| February 16, 2022 Filed Feb 18, 2022 21:34 UTC |
Race GeoffPresident
|
GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.79 | $0.00 |
DisclosureSEC source: 0001209191-22-011304 · doc4.xml · derivative · entry 1 Race Geoff · CIK 0001610382 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-02-15 F1 · derivative.exercise_date: The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 21:33 UTC |
Luthringer RemyDirector · CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 505,000 | $0.00 Strike: $0.79 | $0.00 |
DisclosureSEC source: 0001209191-22-011299 · doc4.xml · derivative · entry 1 Luthringer Remy · CIK 0001610384 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,000 Underlying: Common Stock · 505,000 shares Expires 2032-02-15 F1 · derivative.exercise_date: The option vests 25% on February 16, 2023 and then in equal quarterly installments over 3 years thereafter. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 22:37 UTC |
Kupfer DavidDirector
|
SaleCommon Stock | 55,635 | $0.88 | $48,958.80 |
DisclosureSEC source: 0001209191-21-067938 · doc4.xml · nonDerivative · entry 1 Kupfer David · CIK 0001642053 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,553 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.85 to $0.9235 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:47 UTC |
VAN HEEK G JANDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-21-040683 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:42 UTC |
Laghrissi-Thode FouziaDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-21-040675 · doc4.xml · derivative · entry 1 Laghrissi-Thode Fouzia · CIK 0001642015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:40 UTC |
Kupfer DavidDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-21-040673 · doc4.xml · derivative · entry 1 Kupfer David · CIK 0001642053 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:49 UTC |
DOYLE WILLIAM FDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-21-040687 · doc4.xml · derivative · entry 1 DOYLE WILLIAM F · CIK 0001194459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 40,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 21:47 UTC |
HILLEMAN JERYL LDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-21-040680 · doc4.xml · derivative · entry 1 HILLEMAN JERYL L · CIK 0001216628 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2021 Filed Jun 16, 2021 20:36 UTC |
HASLER HANS PETERDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-21-040932 · doc4.xml · derivative · entry 1 HASLER HANS PETER · CIK 0001226286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2021 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 01:29 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
SaleCommon Stock | 1,845 | $2.64 | $4,870.80 |
DisclosureSEC source: 0001209191-20-063922 · doc4.xml · nonDerivative · entry 2 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,039 F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 01:31 UTC |
Race GeoffEVP, CFO & CBO
|
SaleCommon Stock | 6,190 | $2.64 | $16,341.60 |
DisclosureSEC source: 0001209191-20-063924 · doc4.xml · nonDerivative · entry 2 Race Geoff · CIK 0001610382 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,354 F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 01:37 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
SaleCommon Stock | 3,228 | $2.64 | $8,521.92 |
DisclosureSEC source: 0001209191-20-063926 · doc4.xml · nonDerivative · entry 2 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,747 F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 01:29 UTC |
Luthringer RemyDirector · CEO
|
SaleCommon Stock | 1,300 | $2.64 | $3,432.00 |
DisclosureSEC source: 0001209191-20-063923 · doc4.xml · nonDerivative · entry 2 Luthringer Remy · CIK 0001610384 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,490 F2 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants. Read SEC document |
| December 14, 2020 Filed Dec 17, 2020 01:29 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-063922 · doc4.xml · derivative · entry 3 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F3 · derivative.expiration_date: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| December 14, 2020 Filed Dec 17, 2020 01:29 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-063922 · doc4.xml · nonDerivative · entry 1 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 14, 2020 Filed Dec 17, 2020 01:31 UTC |
Race GeoffEVP, CFO & CBO
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-063924 · doc4.xml · derivative · entry 3 Race Geoff · CIK 0001610382 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F3 · derivative.expiration_date: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| December 14, 2020 Filed Dec 17, 2020 01:31 UTC |
Race GeoffEVP, CFO & CBO
|
Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-063924 · doc4.xml · nonDerivative · entry 1 Race Geoff · CIK 0001610382 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 14, 2020 Filed Dec 17, 2020 01:37 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-063926 · doc4.xml · derivative · entry 3 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F3 · derivative.expiration_date: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| December 14, 2020 Filed Dec 17, 2020 01:37 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-063926 · doc4.xml · nonDerivative · entry 1 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 14, 2020 Filed Dec 17, 2020 01:29 UTC |
Luthringer RemyDirector · CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-063923 · doc4.xml · derivative · entry 4 Luthringer Remy · CIK 0001610384 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. F3 · derivative.expiration_date: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date. Read SEC document |
| December 14, 2020 Filed Dec 17, 2020 01:29 UTC |
Luthringer RemyDirector · CEO
|
Exercise / conversionCommon Stock | 18,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-063923 · doc4.xml · nonDerivative · entry 1 Luthringer Remy · CIK 0001610384 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 17:23 UTC |
Smith Devin WhittemoreSVP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-20-054807 · doc4.xml · derivative · entry 1 Smith Devin Whittemore · CIK 0001747818 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2030-10-12 F1 · derivative.exercise_date: One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 17:20 UTC |
Davidson MichaelChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-20-054804 · doc4.xml · derivative · entry 1 Davidson Michael · CIK 0001691467 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2030-10-12 F1 · derivative.exercise_date: One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 21:18 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-20-054801 · doc4.xml · derivative · entry 1 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2030-10-12 F1 · derivative.exercise_date: One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 21:16 UTC |
Saoud JaySVP and Head of R&D
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-20-054800 · doc4.xml · derivative · entry 1 Saoud Jay · CIK 0001716202 · SVP and Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-10-12 F1 · derivative.exercise_date: One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 21:21 UTC |
Luthringer RemyDirector · CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-20-054805 · doc4.xml · derivative · entry 1 Luthringer Remy · CIK 0001610384 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2030-10-12 F1 · derivative.exercise_date: One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 21:22 UTC |
Race GeoffEVP, CFO & CBO
|
GrantEmployee Stock Option (right to buy) · Derivative | 140,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-20-054806 · doc4.xml · derivative · entry 1 Race Geoff · CIK 0001610382 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2030-10-12 F1 · derivative.exercise_date: One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022. Read SEC document |
| October 13, 2020 Filed Oct 14, 2020 21:19 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-20-054803 · doc4.xml · derivative · entry 1 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2030-10-12 F1 · derivative.exercise_date: One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022. Read SEC document |
| September 10, 2020 Filed Sep 11, 2020 21:13 UTC |
VAN HEEK G JANDirector
|
PurchaseCommon Stock | 7,000 | $2.97 | $20,790.00 |
DisclosureSEC source: 0001209191-20-050176 · doc4.xml · nonDerivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,333 Read SEC document |
| June 19, 2020 Filed Aug 17, 2020 16:32 UTC |
Smith Devin WhittemoreSVP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 153,531 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046957 · doc4.xml · derivative · entry 1 Smith Devin Whittemore · CIK 0001747818 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,531 Underlying: Common Stock · 153,531 shares Expires 2029-12-31 F1 · derivative.exercise_date: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. Read SEC document |
| June 19, 2020 Filed Aug 17, 2020 16:27 UTC |
Davidson MichaelChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 137,784 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046948 · doc4.xml · derivative · entry 1 Davidson Michael · CIK 0001691467 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,784 Underlying: Common Stock · 137,784 shares Expires 2029-12-31 F1 · derivative.exercise_date: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. Read SEC document |
| June 19, 2020 Filed Aug 17, 2020 20:25 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 137,784 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046947 · doc4.xml · derivative · entry 1 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,784 Underlying: Common Stock · 137,784 shares Expires 2029-12-31 F1 · derivative.exercise_date: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. Read SEC document |
| June 19, 2020 Filed Aug 17, 2020 20:31 UTC |
Saoud JaySVP and Head of R&D
|
GrantEmployee Stock Option (right to buy) · Derivative | 236,202 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046954 · doc4.xml · derivative · entry 1 Saoud Jay · CIK 0001716202 · SVP and Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,202 Underlying: Common Stock · 236,202 shares Expires 2029-12-31 F1 · derivative.exercise_date: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. Read SEC document |
| June 19, 2020 Filed Aug 17, 2020 20:30 UTC |
Russell Richard E.President
|
GrantEmployee Stock Option (right to buy) · Derivative | 185,025 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046953 · doc4.xml · derivative · entry 1 Russell Richard E. · CIK 0001724897 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,025 Underlying: Common Stock · 185,025 shares Expires 2029-12-31 F1 · derivative.exercise_date: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. Read SEC document |
| June 19, 2020 Filed Aug 17, 2020 20:30 UTC |
Reilly Joseph H.SVP & Chief Operating Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 153,531 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046952 · doc4.xml · derivative · entry 1 Reilly Joseph H. · CIK 0001610499 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,531 Underlying: Common Stock · 153,531 shares Expires 2029-12-31 F1 · derivative.exercise_date: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. Read SEC document |
| June 19, 2020 Filed Aug 17, 2020 20:29 UTC |
Race GeoffEVP, CFO & CBO
|
GrantEmployee Stock Option (right to buy) · Derivative | 275,568 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046950 · doc4.xml · derivative · entry 1 Race Geoff · CIK 0001610382 · EVP, CFO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,568 Underlying: Common Stock · 275,568 shares Expires 2029-12-31 F1 · derivative.exercise_date: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. Read SEC document |
| June 19, 2020 Filed Aug 17, 2020 20:28 UTC |
Luthringer RemyDirector · CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 354,302 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-046949 · doc4.xml · derivative · entry 1 Luthringer Remy · CIK 0001610384 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,302 Underlying: Common Stock · 354,302 shares Expires 2029-12-31 F1 · derivative.exercise_date: This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 21:02 UTC |
VAN HEEK G JANDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001209191-20-036342 · doc4.xml · derivative · entry 1 VAN HEEK G JAN · CIK 0001021040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 21:01 UTC |
Laghrissi-Thode FouziaDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001209191-20-036339 · doc4.xml · derivative · entry 1 Laghrissi-Thode Fouzia · CIK 0001642015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 21:00 UTC |
Kupfer DavidDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001209191-20-036337 · doc4.xml · derivative · entry 1 Kupfer David · CIK 0001642053 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:57 UTC |
DOYLE WILLIAM FDirector
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001209191-20-036331 · doc4.xml · derivative · entry 1 DOYLE WILLIAM F · CIK 0001194459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. An additional option grant to purchase 20,000 shares of common stock was granted to the Reporting Person at the discretion of the Company's board of directors for such Reporting Person's service as lead independent director. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:59 UTC |
HILLEMAN JERYL LDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001209191-20-036336 · doc4.xml · derivative · entry 1 HILLEMAN JERYL L · CIK 0001216628 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:58 UTC |
HASLER HANS PETERDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001209191-20-036335 · doc4.xml · derivative · entry 1 HASLER HANS PETER · CIK 0001226286 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-10 F1 · security: This option is granted to non-employee directors in accordance with the Company's compensation program for non-employee directors, which provides that each non-employee director is eligible to receive an annual option grant to purchase 20,000 shares of common stock per year. F2 · derivative.exercise_date: The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 11, 2020 and an additional 1/4 every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date. Read SEC document |
| May 26, 2020 Filed May 27, 2020 20:43 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
SaleCommon Stock | 8,339 | $15.00 | $125,085.00 |
DisclosureSEC source: 0001209191-20-032322 · doc4.xml · nonDerivative · entry 1 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,884 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2019. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 16:53 UTC |
Smith Devin WhittemoreSVP and General Counsel
|
GrantEmployee Stock Option (right to buy) · Derivative | 41,469 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-001129 · doc4.xml · derivative · entry 1 Smith Devin Whittemore · CIK 0001747818 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,469 Underlying: Common Stock · 41,469 shares Expires 2029-12-30 F1 · derivative.exercise_date: This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 16:47 UTC |
Davidson MichaelChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 37,216 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-001103 · doc4.xml · derivative · entry 1 Davidson Michael · CIK 0001691467 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,216 Underlying: Common Stock · 37,216 shares Expires 2029-12-30 F1 · derivative.exercise_date: This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:46 UTC |
Ahlholm Frederick WSVP, Chief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 37,216 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-001096 · doc4.xml · derivative · entry 1 Ahlholm Frederick W · CIK 0001405279 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,216 Underlying: Common Stock · 37,216 shares Expires 2029-12-30 F1 · derivative.exercise_date: This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:52 UTC |
Saoud JaySVP and Head of R&D
|
GrantEmployee Stock Option (right to buy) · Derivative | 63,798 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-001125 · doc4.xml · derivative · entry 1 Saoud Jay · CIK 0001716202 · SVP and Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,798 Underlying: Common Stock · 63,798 shares Expires 2029-12-30 F1 · derivative.exercise_date: This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:51 UTC |
Russell Richard E.President
|
GrantEmployee Stock Option (right to buy) · Derivative | 49,975 | $0.00 Strike: $7.11 | $0.00 |
DisclosureSEC source: 0001209191-20-001119 · doc4.xml · derivative · entry 1 Russell Richard E. · CIK 0001724897 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,975 Underlying: Common Stock · 49,975 shares Expires 2029-12-30 F1 · derivative.exercise_date: This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.